1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Cell Viability Assays Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Human Cells 1.2.3 Microbial Cells 1.2.4 Animal Cells 1.3 Market by Application 1.3.1 Global Cell Viability Assays Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Pharmaceutical and Biotechnology Companies 1.3.3 Academic and Research Institutes 1.3.4 Hospital and Diagnostic Laboratories 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Cell Viability Assays Market Perspective (2017-2028) 2.2 Cell Viability Assays Growth Trends by Region 2.2.1 Cell Viability Assays Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Cell Viability Assays Historic Market Size by Region (2017-2022) 2.2.3 Cell Viability Assays Forecasted Market Size by Region (2023-2028) 2.3 Cell Viability Assays Market Dynamics 2.3.1 Cell Viability Assays Industry Trends 2.3.2 Cell Viability Assays Market Drivers 2.3.3 Cell Viability Assays Market Challenges 2.3.4 Cell Viability Assays Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Cell Viability Assays Players by Revenue 3.1.1 Global Top Cell Viability Assays Players by Revenue (2017-2022) 3.1.2 Global Cell Viability Assays Revenue Market Share by Players (2017-2022) 3.2 Global Cell Viability Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Cell Viability Assays Revenue 3.4 Global Cell Viability Assays Market Concentration Ratio 3.4.1 Global Cell Viability Assays Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Cell Viability Assays Revenue in 2021 3.5 Cell Viability Assays Key Players Head office and Area Served 3.6 Key Players Cell Viability Assays Product Solution and Service 3.7 Date of Enter into Cell Viability Assays Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Cell Viability Assays Breakdown Data by Type 4.1 Global Cell Viability Assays Historic Market Size by Type (2017-2022) 4.2 Global Cell Viability Assays Forecasted Market Size by Type (2023-2028) 5 Cell Viability Assays Breakdown Data by Application 5.1 Global Cell Viability Assays Historic Market Size by Application (2017-2022) 5.2 Global Cell Viability Assays Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Cell Viability Assays Market Size (2017-2028) 6.2 North America Cell Viability Assays Market Size by Country (2017-2022) 6.3 North America Cell Viability Assays Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe Cell Viability Assays Market Size (2017-2028) 7.2 Europe Cell Viability Assays Market Size by Country (2017-2022) 7.3 Europe Cell Viability Assays Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Cell Viability Assays Market Size (2017-2028) 8.2 Asia-Pacific Cell Viability Assays Market Size by Country (2017-2022) 8.3 Asia-Pacific Cell Viability Assays Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America Cell Viability Assays Market Size (2017-2028) 9.2 Latin America Cell Viability Assays Market Size by Country (2017-2022) 9.3 Latin America Cell Viability Assays Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Cell Viability Assays Market Size (2017-2028) 10.2 Middle East & Africa Cell Viability Assays Market Size by Country (2017-2022) 10.3 Middle East & Africa Cell Viability Assays Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Thermo Fisher Scientific 11.1.1 Thermo Fisher Scientific Company Detail 11.1.2 Thermo Fisher Scientific Business Overview 11.1.3 Thermo Fisher Scientific Cell Viability Assays Introduction 11.1.4 Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022) 11.1.5 Thermo Fisher Scientific Recent Development 11.2 Merck 11.2.1 Merck Company Detail 11.2.2 Merck Business Overview 11.2.3 Merck Cell Viability Assays Introduction 11.2.4 Merck Revenue in Cell Viability Assays Business (2017-2022) 11.2.5 Merck Recent Development 11.3 Bio-Rad 11.3.1 Bio-Rad Company Detail 11.3.2 Bio-Rad Business Overview 11.3.3 Bio-Rad Cell Viability Assays Introduction 11.3.4 Bio-Rad Revenue in Cell Viability Assays Business (2017-2022) 11.3.5 Bio-Rad Recent Development 11.4 GE 11.4.1 GE Company Detail 11.4.2 GE Business Overview 11.4.3 GE Cell Viability Assays Introduction 11.4.4 GE Revenue in Cell Viability Assays Business (2017-2022) 11.4.5 GE Recent Development 11.5 Danaher 11.5.1 Danaher Company Detail 11.5.2 Danaher Business Overview 11.5.3 Danaher Cell Viability Assays Introduction 11.5.4 Danaher Revenue in Cell Viability Assays Business (2017-2022) 11.5.5 Danaher Recent Development 11.6 BD 11.6.1 BD Company Detail 11.6.2 BD Business Overview 11.6.3 BD Cell Viability Assays Introduction 11.6.4 BD Revenue in Cell Viability Assays Business (2017-2022) 11.6.5 BD Recent Development 11.7 PerkinElmer 11.7.1 PerkinElmer Company Detail 11.7.2 PerkinElmer Business Overview 11.7.3 PerkinElmer Cell Viability Assays Introduction 11.7.4 PerkinElmer Revenue in Cell Viability Assays Business (2017-2022) 11.7.5 PerkinElmer Recent Development 11.8 Promega 11.8.1 Promega Company Detail 11.8.2 Promega Business Overview 11.8.3 Promega Cell Viability Assays Introduction 11.8.4 Promega Revenue in Cell Viability Assays Business (2017-2022) 11.8.5 Promega Recent Development 11.9 Biotium 11.9.1 Biotium Company Detail 11.9.2 Biotium Business Overview 11.9.3 Biotium Cell Viability Assays Introduction 11.9.4 Biotium Revenue in Cell Viability Assays Business (2017-2022) 11.9.5 Biotium Recent Development 11.10 Abcam 11.10.1 Abcam Company Detail 11.10.2 Abcam Business Overview 11.10.3 Abcam Cell Viability Assays Introduction 11.10.4 Abcam Revenue in Cell Viability Assays Business (2017-2022) 11.10.5 Abcam Recent Development 11.11 Creative Bioarray 11.11.1 Creative Bioarray Company Detail 11.11.2 Creative Bioarray Business Overview 11.11.3 Creative Bioarray Cell Viability Assays Introduction 11.11.4 Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022) 11.11.5 Creative Bioarray Recent Development 11.12 Biotek Instruments 11.12.1 Biotek Instruments Company Detail 11.12.2 Biotek Instruments Business Overview 11.12.3 Biotek Instruments Cell Viability Assays Introduction 11.12.4 Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022) 11.12.5 Biotek Instruments Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Cell Viability Assays Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Human Cells Table 3. Key Players of Microbial Cells Table 4. Key Players of Animal Cells Table 5. Global Cell Viability Assays Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global Cell Viability Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Cell Viability Assays Market Share by Region (2017-2022) Table 9. Global Cell Viability Assays Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Cell Viability Assays Market Share by Region (2023-2028) Table 11. Cell Viability Assays Market Trends Table 12. Cell Viability Assays Market Drivers Table 13. Cell Viability Assays Market Challenges Table 14. Cell Viability Assays Market Restraints Table 15. Global Cell Viability Assays Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Cell Viability Assays Market Share by Players (2017-2022) Table 17. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021) Table 18. Ranking of Global Top Cell Viability Assays Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Cell Viability Assays Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Cell Viability Assays Product Solution and Service Table 22. Date of Enter into Cell Viability Assays Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Cell Viability Assays Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Cell Viability Assays Revenue Market Share by Type (2017-2022) Table 26. Global Cell Viability Assays Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Cell Viability Assays Revenue Market Share by Type (2023-2028) Table 28. Global Cell Viability Assays Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Cell Viability Assays Revenue Market Share by Application (2017-2022) Table 30. Global Cell Viability Assays Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Cell Viability Assays Revenue Market Share by Application (2023-2028) Table 32. North America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million) Table 33. North America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million) Table 34. Europe Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million) Table 35. Europe Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million) Table 36. Asia-Pacific Cell Viability Assays Market Size by Region (2017-2022) & (US$ Million) Table 37. Asia-Pacific Cell Viability Assays Market Size by Region (2023-2028) & (US$ Million) Table 38. Latin America Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million) Table 39. Latin America Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million) Table 40. Middle East & Africa Cell Viability Assays Market Size by Country (2017-2022) & (US$ Million) Table 41. Middle East & Africa Cell Viability Assays Market Size by Country (2023-2028) & (US$ Million) Table 42. Thermo Fisher Scientific Company Detail Table 43. Thermo Fisher Scientific Business Overview Table 44. Thermo Fisher Scientific Cell Viability Assays Product Table 45. Thermo Fisher Scientific Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 46. Thermo Fisher Scientific Recent Development Table 47. Merck Company Detail Table 48. Merck Business Overview Table 49. Merck Cell Viability Assays Product Table 50. Merck Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 51. Merck Recent Development Table 52. Bio-Rad Company Detail Table 53. Bio-Rad Business Overview Table 54. Bio-Rad Cell Viability Assays Product Table 55. Bio-Rad Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 56. Bio-Rad Recent Development Table 57. GE Company Detail Table 58. GE Business Overview Table 59. GE Cell Viability Assays Product Table 60. GE Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 61. GE Recent Development Table 62. Danaher Company Detail Table 63. Danaher Business Overview Table 64. Danaher Cell Viability Assays Product Table 65. Danaher Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 66. Danaher Recent Development Table 67. BD Company Detail Table 68. BD Business Overview Table 69. BD Cell Viability Assays Product Table 70. BD Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 71. BD Recent Development Table 72. PerkinElmer Company Detail Table 73. PerkinElmer Business Overview Table 74. PerkinElmer Cell Viability Assays Product Table 75. PerkinElmer Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 76. PerkinElmer Recent Development Table 77. Promega Company Detail Table 78. Promega Business Overview Table 79. Promega Cell Viability Assays Product Table 80. Promega Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 81. Promega Recent Development Table 82. Biotium Company Detail Table 83. Biotium Business Overview Table 84. Biotium Cell Viability Assays Product Table 85. Biotium Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 86. Biotium Recent Development Table 87. Abcam Company Detail Table 88. Abcam Business Overview Table 89. Abcam Cell Viability Assays Product Table 90. Abcam Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 91. Abcam Recent Development Table 92. Creative Bioarray Company Detail Table 93. Creative Bioarray Business Overview Table 94. Creative Bioarray Cell Viability AssaysProduct Table 95. Creative Bioarray Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 96. Creative Bioarray Recent Development Table 97. Biotek Instruments Company Detail Table 98. Biotek Instruments Business Overview Table 99. Biotek Instruments Cell Viability AssaysProduct Table 100. Biotek Instruments Revenue in Cell Viability Assays Business (2017-2022) & (US$ Million) Table 101. Biotek Instruments Recent Development Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Cell Viability Assays Market Share by Type: 2021 VS 2028 Figure 2. Human Cells Features Figure 3. Microbial Cells Features Figure 4. Animal Cells Features Figure 5. Global Cell Viability Assays Market Share by Application in 2021 & 2028 Figure 6. Pharmaceutical and Biotechnology Companies Case Studies Figure 7. Academic and Research Institutes Case Studies Figure 8. Hospital and Diagnostic Laboratories Case Studies Figure 9. Others Case Studies Figure 10. Cell Viability Assays Report Years Considered Figure 11. Global Cell Viability Assays Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Cell Viability Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Cell Viability Assays Market Share by Region: 2021 VS 2028 Figure 14. Global Cell Viability Assays Market Share by Players in 2021 Figure 15. Global Top Cell Viability Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Viability Assays as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Cell Viability Assays Revenue in 2021 Figure 17. North America Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 18. North America Cell Viability Assays Market Share by Country (2017-2028) Figure 19. United States Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Canada Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Europe Cell Viability Assays Market Share by Country (2017-2028) Figure 23. Germany Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. France Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. U.K. Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Italy Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Russia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Nordic Countries Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Asia-Pacific Cell Viability Assays Market Share by Region (2017-2028) Figure 31. China Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Japan Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. South Korea Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. Southeast Asia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. India Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Australia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Latin America Cell Viability Assays Market Share by Country (2017-2028) Figure 39. Mexico Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Brazil Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Middle East & Africa Cell Viability Assays Market Share by Country (2017-2028) Figure 43. Turkey Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Saudi Arabia Cell Viability Assays Market Size YoY Growth (2017-2028) & (US$ Million) Figure 45. Thermo Fisher Scientific Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 46. Merck Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 47. Bio-Rad Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 48. GE Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 49. Danaher Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 50. BD Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 51. PerkinElmer Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 52. Promega Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 53. Biotium Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 54. Abcam Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 55. Creative Bioarray Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 56. Biotek Instruments Revenue Growth Rate in Cell Viability Assays Business (2017-2022) Figure 57. Bottom-up and Top-down Approaches for This Report Figure 58. Data Triangulation Figure 59. Key Executives Interviewed

Thermo Fisher Scientific Merck Bio-Rad GE Danaher BD PerkinElmer Promega Biotium Abcam Creative Bioarray Biotek Instruments